Ryan Van Wert’s career has a useful starting date: 2012. That was the beginning of his Stanford Biodesign Innovation Fellowship, a year he shared with Rush Bartlett. The two would become business partners. Their work would produce AWAIR and Vynca, companies with different products and different paths. Before those names existed, however, there was a more demanding assignment: find a problem worth spending years on.
That sequence gives his story its shape. A fellowship becomes a company. A company becomes an organization with investors, employees and a successor in the chief executive’s chair. Meanwhile, the founder returns to the classroom. Van Wert’s working life crosses these settings often enough that the usual division between learning and doing begins to look rather untidy.
The temptation in a founder profile is to begin at the funding announcement and work backward, as though an investment were the event that made everything before it meaningful. Van Wert’s chronology invites a different reading. The early work happened before a financing round could give it a price tag. It involved observation, research and the willingness to reconsider an attractive answer.
There is something pleasantly unfashionable about this. A startup can acquire a name in an afternoon. Understanding why it should exist takes longer. Van Wert’s story is interesting in that interval, when the future company is still a set of questions and nobody has ordered the branded stationery.
Two partners, two routes
At Biodesign, Van Wert and Bartlett investigated needs together, studying published research, watching work as it happened and speaking with people doing it. They also looked across different settings for practices that might explain what they were seeing. That habit of comparison mattered: the answer to a problem need not originate in the place where the problem first becomes visible.
Their company AWAIR was acquired by Cook Medical in 2015. Vynca, launched in 2013, continued on a different course. Put those two outcomes beside each other and a useful distinction appears. Founding a company does not commit its founders to one standard ending. A transaction and a continuing independent business can emerge from the same partnership and the same training.
This is also a story about collaboration. Bartlett’s background included engineering and business training; Van Wert brought a different professional education. Their names recur together in the early history of both companies. Later, Frank Wang appears in Vynca’s founding team as its chief technology officer. The organization’s beginnings belong to a group, with expertise distributed among people.
That detail prevents the biography from turning into a solo performance. A founder may be the person who explains a company in public, but explanation and construction are different jobs. Vynca’s history has room for partners, engineers and an early customer, each making decisions that the others could not make on their behalf.
A first customer has questions
For Vynca, securing the first customer was a substantial obstacle. The early team connected with Oregon Health and Science University at a moment when the institution had a technical project underway. Working together on development and testing gave the young company an opening. The partnership required the team to make its technology credible inside an existing organization.
Van Wert identified interoperability as an early requirement. The term is dry, but its implication is quite social. Systems already have users, habits and responsibilities. A new product has to live among them. Its arrival creates work for someone else, and that person is entitled to ask rather pointed questions.
In a large institution, the buyer’s doubts are part of the problem a startup must solve. Who will support the product? What happens when something goes wrong? How much existing work must change? A demonstration can show that a tool functions. A working relationship has to establish that its makers will stay engaged after the demonstration ends.
Seen this way, a first customer is also a first test of the company itself. There is no long operating history to point to. The founders must make commitments, listen carefully and deliver something other people can depend on. The meeting may occupy an hour on the calendar; the obligation it creates can occupy years.
“system interoperability would be essential from the start”Ryan Van Wert, on Vynca’s early design requirements
Capital arrives with a calendar
By June 2019, Vynca announced a $10.3 million Series B. First Trust Capital Partners, OCA Ventures and Spectrum Health Ventures participated, alongside other investors. The money was designated for geographic expansion and product development. The announcement also brought board appointments and a board observer, making the company’s governance part of its next stage.
On January 31, 2022, Vynca announced another $30 million in growth capital, led by Questa Capital with participation from existing investors. Van Wert was then its CEO and co-founder. The stated uses included building the organization and developing its technology. These were company financing events, with company obligations attached.
The two figures look tidy when placed on a page. They describe rounds at different dates and stages, rather than a continuous measure of performance. Nor do they describe the founder’s personal fortune. What they establish is that the company attracted capital more than once as its ambitions and operating requirements developed.
For a founder, funding changes the calendar. Hiring and development plans become commitments with budgets behind them. Investors join the conversation. The question of what to build acquires companions: who will build it, how long it will take and what the organization must do to support it. A round closes on a date; spending it well is a continuing assignment.
The founder’s chair changes hands
In 2023, Darren Schulte became Vynca’s CEO, succeeding Van Wert. That puts an important boundary around the description “co-founder and former CEO.” The founding credit remains part of Van Wert’s history. The executive title belongs to a particular period, and the company continued with another person leading it.
A succession date makes the story more precise. Vynca began in 2013 and changed chief executives a decade later. The interval includes early development, institutional partnerships, investment and expansion. It is a substantial stretch of company life, with the founder’s role changing as the organization moved beyond its earliest form.
Succession also gives a profile a useful place to pause. Businesses often outlast the particular jobs their founders hold. A company’s later decisions belong to the people making them at that time. Respecting that distinction gives both the founder and the succeeding leadership their proper place in the account.
Van Wert’s subsequent roles make the transition especially interesting. Kin Concierge identifies him as its founder. Affineon lists him as chief medical officer, alongside CEO Evan Grossman and chief technical officer Tony Karrer. The pattern is a working career with several chapters: founding, leading, joining another leadership team and teaching. A biography can follow those changes without pretending they amount to a single uninterrupted job.
Back on the other side of the seminar
Van Wert’s education took him through the University of Toronto and then Stanford. His Stanford profile records education completed in Toronto in 2006, subsequent training there, and a Stanford fellowship completed in 2013. The Biodesign Innovation Fellowship ran during 2012-13, linking that period of training to the beginning of his entrepreneurial work.
His university appointments continued after the startups appeared. Stanford lists an assistant director role in the Biodesign Faculty Fellowship beginning in 2015. Its current Digital Health team identifies him as an associate director. The executive education program also includes him among its leaders. These appointments put teaching and company-building alongside one another in his career.
The connection is practical. A founder who returns to teaching has examples that resist the neatness of a slide deck: different company outcomes, the difficulty of winning an early customer, a financing round and a leadership transition. Students can examine decisions that had consequences beyond a classroom exercise. The value lies in the particulars.
For the teacher, the classroom brings another obligation: make experience intelligible to people who were absent when it happened. A familiar story needs enough detail to become useful. What did the team know? What remained uncertain? Which decision could wait, and which could not? Those questions turn a career anecdote into something another builder can think with.
Another company, the same opening question
Kin Concierge is the newest founding chapter in this account. The company describes a service built around coordination and support for families, with a presence in Los Angeles, Orange County and the San Francisco Bay Area, and advisory availability across the United States. Its public description emphasizes giving families time back. That is a service proposition with a human unit of measurement.
The company also publishes the Kin Report, with Van Wert appearing as an author. Writing adds another way to explain his work, alongside the university classroom and the executive role. Each format asks for a different kind of clarity. A business must make its offer understandable; a teacher must make a method usable; an author must give a reader a reason to continue.
On January 13, 2026, he appeared on the podcast First in Human for a 48-minute conversation about choosing problems and building companies. The discussion revisited AWAIR, Vynca and Kin. It offered a current point in a career whose early entrepreneurial dates now sit more than a decade in the past.
Across those chapters, the opening question remains useful. Which problem deserves a company, and what must be understood before the company starts? Van Wert’s record gives that question several settings and several outcomes. A fellowship, a partnership, an acquisition, investment, succession and another venture all fit into the account. The work before the breakthrough turns out to have a long afterlife.